IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Insys Therapeutics Inc New

CUSIP: 45824V909 | 5 institutional holders

Quarters

Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile